title: Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence.
abstract: Streptococcus pneumoniae is an important cause of otitis media and invasive disease. Since introduction of the heptavalent pneumococcal conjugate vaccine, there has been an increase in replacement disease due to serotype 19A clonal complex (CC)199 isolates. The goals of this study were to 1) describe genetic diversity among nineteen CC199 isolates from carriage, middle ear, blood, and cerebrospinal fluid, 2) compare CC199 19A (n = 3) and 15B/C (n = 2) isolates in the chinchilla model for pneumococcal disease, and 3) identify accessory genes associated with tissue-specific disease among a larger collection of S. pneumoniae isolates. CC199 isolates were analyzed by comparative genome hybridization. One hundred and twenty-seven genes were variably present. The CC199 phylogeny split into two main clades, one comprised predominantly of carriage isolates and another of disease isolates. Ability to colonize and cause disease did not differ by serotype in the chinchilla model. However, isolates from the disease clade were associated with faster time to bacteremia compared to carriage clade isolates. One 19A isolate exhibited hypervirulence. Twelve tissue-specific genes/regions were identified by correspondence analysis. After screening a diverse collection of 326 isolates, spr0282 was associated with carriage. Four genes/regions, SP0163, SP0463, SPN05002 and RD8a were associated with middle ear isolates. SPN05002 also associated with blood and CSF, while RD8a associated with blood isolates. The hypervirulent isolate's genome was sequenced using the Solexa paired-end sequencing platform and compared to that of a reference serotype 19A isolate, revealing the presence of a novel 20 kb region with sequence similarity to bacteriophage genes. Genetic factors other than serotype may modulate virulence potential in CC199. These studies have implications for the long-term effectiveness of conjugate vaccines. Ideally, future vaccines would target common proteins to effectively reduce carriage and disease in the vaccinated population.
authors.affiliation: Division of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University School of Medicine, New Haven, Connecticut, United States of America.
authors.forename: Jonathan C
authors.initials: JC
authors.lastname: Thomas
authors.forename: Marisol
authors.initials: M
authors.lastname: Figueira
authors.forename: Kristopher P
authors.initials: KP
authors.lastname: Fennie
authors.forename: Alison S
authors.initials: AS
authors.lastname: Laufer
authors.forename: Yong
authors.initials: Y
authors.lastname: Kong
authors.forename: Michael E
authors.initials: ME
authors.lastname: Pichichero
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Pelton
authors.forename: Melinda M
authors.initials: MM
authors.lastname: Pettigrew
mesh_terms: D000818:Animals; D002682:Chinchilla; D004195:Disease Models, Animal; D005798:Genes, Bacterial; D014644:Genetic Variation; D011008:Pneumococcal Infections / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000235:genetics* / Q000472:pathogenicity; D014774:Virulence